April 06, 2021 2 min read Source/Disclosures Disclosures: One study author reports receiving a grant from the NIMH. The other authors report no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to […]
Polygenic scores may identify long-term risk for depression, resilience Read More »
Cells from individuals with Major Depressive Disorder (MDD) were found to have higher than expected rates of methylation at specific sites on their DNA, when compared to cells from healthy individuals without MDD, according to a study by a multidisciplinary team of UC San Francisco scientists, in collaboration with others. Methylation is a process by
Accelerated Cellular Aging Associated with Mortality Seen in Depressed Individuals Read More »
A recently published study in Arthritis Care & Research found anxiety and depression symptoms reduced the possibility of achieving sustained minimal disease activity in psoriatic arthritis (PsA).1 “The number of comorbidities may be variable in PsA patients, but around 50% of patients are afflicted by at least one comorbidity,” the study authors wrote. “Anxiety and depression
The coronavirus pandemic has taxed America’s mental health system over the past year and one thing is clear: young adults are having the hardest time coping out of any age group. Loneliness, anxiety and depression are putting extra pressure on the group at a time in their lives that’s already typically filled with disruption. If
Loneliness, Anxiety, Depression. Pandemic Takes A Toll On Idaho Youth Mental Health Read More »
Cells from individuals with Major Depressive Disorder (MDD) were found to have higher than expected rates of methylation at specific sites on their DNA, when compared to cells from healthy individuals without MDD, according to a study by a multidisciplinary team of UC San Francisco scientists, in collaboration with others. Methylation is a process by
Accelerated cellular aging associated with mortality seen in depressed individuals Read More »
The coronavirus pandemic has taxed America’s mental health system over the past year and one thing is clear: young adults are having the hardest time coping out of any age group. Loneliness, anxiety and depression are putting extra pressure on the group at a time in their lives that’s already typically filled with disruption. If
Loneliness, Anxiety, Depression. Pandemic Takes A Toll On Idaho Youth Mental Health Read More »
Street trees can help reduce the need for antidepressants among city dwellers, according to new research. Its findings back up studies that indicate time spent among foliage and in nature can help relieve a number of stress-related conditions. Socio-economic inequalities often correlate with inequalities in tree distribution. Planting more urban trees could help address this
City trees can help reduce stress and depression – study Read More »
The CEO of Genies has struggled with anxiety and depression, but his avatar is helping him. Akash Nigam Imagine a digital avatar and you may think of a video game, virtual conference, or social media feature. Genies CEO, Akash Nigam, has a different vision of what digital avatars can be. By his LinkedIn profile, it
Extrapulmonary comorbidities, such as cardiovascular disease and diabetes, are highly prevalent in COPD. Additionally, previous studies suggest that depression affects between 24.6% and 27.1% pf patients with COPD. Also, one study found that around 40% of patients with COPD experienced depressive symptoms. “The high prevalence of depression and anxiety is concerning because these problems are
SAINT-CLOUD, France, April 6, 2021 /PRNewswire/ — Ethypharm announces today that it has acquired exclusive rights for two CE-marked digital therapies, deprexis® and vorvida®, developed by GAIA AG (GAIA), a global leader in digital therapeutics. With these innovative clinically-proven digital therapies, Ethypharm strengthens its product offering to support patients and healthcare providers in its core area